/sixth-igwg-meeting-on-the-who-pandemic-agreement.tmb-1200v.jpg?sfvrsn=5788659a_1)
World Health Organization (WHO) Member States have agreed to extend negotiations on the Pathogen Access and Benefit Sharing (PABS) annex to the WHO Pandemic Agreement, with discussions to resume in late-April ahead of its scheduled consideration by the World Health Assembly (WHA) in May.
The decision to continue negotiations from 27 April–1 May, with informal intersessional discussions taking place in advance, reflects the commitment by WHO Member States to negotiate the PABS annex, a core component of the WHO Pandemic Agreement.
The World Health Assembly adopted the Pandemic Agreement last year to address weaknesses exposed by the COVID-19 pandemic and to strengthen global cooperation and equity in future pandemic prevention, preparedness and response.
“The Pathogen Access and Benefit Sharing system lies at the heart of the WHO Pandemic Agreement and I thank WHO Member States for their commitment to work to bring it to life,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “I urge all delegations to believe in the power of trust – trust in one another, in our institutions, and in our shared ability to transcend differences for the common public good, for solidarity and for equity.”
The PABS annex is intended to ensure, on equal footing, the rapid sharing of pathogens with pandemic potential and the fair and equitable sharing of benefits arising from their use, including vaccines, diagnostics and therapeutics.
“Member State negotiators are working intensively towards having an ambitious and equitable Pathogen Access and Benefits Sharing annex ready for adoption at the World Health Assembly in May,” said IGWG Bureau Co-Chair Ambassador Tovar da Silva Nunes, of Brazil.
During the past week, Member States engaged in intensive negotiations under the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement. Discussions covered a range of critical and interlinked issues, including how benefits derived from the sharing of pathogens should be defined and distributed, the nature of contractual arrangements underpinning the PABS system, and governance matters necessary to ensure the system functions effectively, transparently and in the public interest.
“With less than two months until the World Health Assembly in May, I welcome the commitment shown this week by Member States towards finding consensus on outstanding areas in the Pathogen Access and Benefit Sharing system,” said IGWG Bureau Co-Chair Mr Matthew Harpur, of the United Kingdom of Great Britain and Northern Ireland.
Member States acknowledged the constructive engagement to date, while recognizing that additional time is needed to bridge remaining differences to finalize the text and submit the outcome to the World Health Assembly. They also reaffirmed their commitment to solidarity, multilateralism and the shared goal of making the world safer and more equitable in the face of future pandemics.
Facts Only
WHO Member States agreed to extend negotiations on the PABS annex to the WHO Pandemic Agreement.
Discussions will resume from 27 April to 1 May, with informal intersessional talks beforehand.
The PABS annex is a core component of the WHO Pandemic Agreement, adopted last year.
The system aims to ensure rapid sharing of pathogens with pandemic potential and equitable benefit-sharing.
Negotiations are led by the Intergovernmental Working Group (IGWG) on the WHO Pandemic Agreement.
Key issues include defining and distributing benefits, contractual arrangements, and governance transparency.
The World Health Assembly will consider the annex in May.
Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, emphasized trust and solidarity among Member States.
IGWG Bureau Co-Chairs include Ambassador Tovar da Silva Nunes (Brazil) and Mr. Matthew Harpur (UK).
Member States acknowledged progress but recognized the need for more time to finalize the text.
The Pandemic Agreement seeks to address weaknesses exposed by the COVID-19 pandemic.
The goal is to strengthen global cooperation and equity in pandemic prevention, preparedness, and response.
Executive Summary
Full Take
The strongest version of this narrative highlights a genuine effort by WHO Member States to bridge gaps in global pandemic preparedness through multilateral cooperation. The emphasis on trust, equity, and transparency in the PABS system reflects a recognition of past failures, particularly during COVID-19, where disparities in vaccine access and pathogen data-sharing undermined global solidarity. The extension of negotiations signals a commitment to getting the details right, rather than rushing a flawed agreement. However, the repeated calls for "trust" and "solidarity" may also serve as rhetorical tools to obscure deeper tensions—such as disagreements over intellectual property rights, benefit-sharing mechanisms, or enforcement—without addressing structural inequities in global health governance.
Patterns detected: ARC-0024 Ambiguity (vague appeals to "trust" without concrete mechanisms), ARC-0043 Motte-and-Bailey (broad principles like "equity" used to justify specific, contested policies).
The root cause of this narrative is the tension between national sovereignty and global health security. The unstated assumption is that equitable benefit-sharing can be achieved without fundamentally challenging existing power imbalances in pharmaceutical production and distribution. Historically, this echoes past debates over the WHO’s Framework Convention on Tobacco Control or the TRIPS waiver discussions, where high-income countries often resisted binding commitments.
For human agency, the implications are mixed. On one hand, the PABS system could empower lower-income countries by ensuring access to life-saving tools. On the other, if the final text lacks enforceable mechanisms, it may entrench dependency on wealthier nations or private actors. Second-order consequences could include delays in pandemic response if negotiations drag on, or a weakened WHO if Member States fail to reach consensus.
Bridge questions: What specific mechanisms would ensure that benefits are distributed fairly, not just promised? How might the PABS system interact with existing intellectual property regimes? What would it take for skepticism about this process to be justified?
Counterstrike scan: A bad actor pushing this narrative might exaggerate the urgency to pressure Member States into accepting a weak agreement, or frame dissent as "undermining global health." The actual content does not match this pattern—it acknowledges unresolved differences and the need for further negotiation, which is a healthy sign of deliberative process.
Sentinel — Human
This text shows signs of being written by a human, with varied sentence structure, passionate quotes, and no fabrication risks detected.